GPS Wealth Strategies Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $235K | Sell |
447
-53
| -11% | -$27.8K | 0.03% | 302 |
|
2025
Q1 | $317K | Sell |
500
-71
| -12% | -$45K | 0.04% | 234 |
|
2024
Q4 | $407K | Sell |
571
-60
| -10% | -$42.7K | 0.05% | 198 |
|
2024
Q3 | $664K | Buy |
631
+37
| +6% | +$38.9K | 0.09% | 150 |
|
2024
Q2 | $625K | Buy |
594
+82
| +16% | +$86.2K | 0.09% | 134 |
|
2024
Q1 | $492K | Sell |
512
-1
| -0.2% | -$962 | 0.08% | 155 |
|
2023
Q4 | $451K | Buy |
513
+70
| +16% | +$61.5K | 0.08% | 159 |
|
2023
Q3 | $365K | Buy |
443
+35
| +9% | +$28.8K | 0.07% | 174 |
|
2023
Q2 | $293K | Buy |
408
+153
| +60% | +$110K | 0.05% | 201 |
|
2023
Q1 | $210K | Buy |
+255
| New | +$210K | 0.04% | 234 |
|
2022
Q4 | – | Sell |
-229
| Closed | -$158K | – | 869 |
|
2022
Q3 | $158K | Sell |
229
-2
| -0.9% | -$1.38K | 0.04% | 233 |
|
2022
Q2 | $137K | Sell |
231
-11
| -5% | -$6.52K | 0.04% | 261 |
|
2022
Q1 | $169K | Buy |
242
+19
| +9% | +$13.3K | 0.04% | 232 |
|
2021
Q4 | $141K | Buy |
223
+27
| +14% | +$17.1K | 0.03% | 247 |
|
2021
Q3 | $119K | Buy |
196
+64
| +48% | +$38.9K | 0.03% | 257 |
|
2021
Q2 | $74K | Hold |
132
| – | – | 0.02% | 347 |
|
2021
Q1 | $62K | Buy |
+132
| New | +$62K | 0.02% | 346 |
|